Definium Therapeutics, Inc.
About
22.45USD+1.58 +7.57%
Closed • Updated at 18:16 GMT+00:00Market Cap$2.45B
Volume1.13M
Beta1.77
RSI56.18
Definium Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Today
Definium Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
May 12 2026
Definium Therapeutics Announces First Patient Dosed in Ascend, the Second Phase 3 Pivotal Study of DT120 ODT in Major Depressive Disorder
May 7 2026
Definium Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights
Apr 30 2026
Definium Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026
Apr 22 2026
Definium Therapeutics Highlights DT120 ODT (Lysergide Tartrate) Clinical Advancements and Commercial Strategy at Investor and Analyst Day